1. Home
  2. CNSP

as of 12-12-2025 10:49am EST

$7.90
+$0.25
+3.22%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Chart Type:
Time Range:
Founded: 2017 Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 4.3M IPO Year: 2019
Target Price: $20.00 AVG Volume (30 days): 10.1K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -41.85 EPS Growth: N/A
52 Week Low/High: $4.93 - $114.00 Next Earning Date: 11-17-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered CNSP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 81.63%
81.63%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: